Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gold

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2010
Detection of early-stage pancreatic adenocarcinomaDavid V Gold, Michael Goggins, David E Modrak, et al.
Cell Death and Differentiation|April 3, 2004
BMP controls nitric oxide-mediated regulation of cell numbers in the developing neural tubeA Traister, S Abashidze, V Gold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.
Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.
Cancer Research|June 19, 2008
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinomaDavid V Gold, David M Goldenberg, Habibe Karacay, et al.
Cancer Research|December 1, 1995
Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancerG Mariani, N Molea, D Bacciardi, et al.
International Journal of Cancer|July 29, 2011
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivoDavid M Goldenberg, David Zagzag, Kerstin M Heselmeyer-Haddad, et al.
Molecular Cytogenetics|March 22, 2022
New insights regarding origin of monosomy occurrence in early developing embryos as demonstrated in preimplantation genetic testingN Samara, S Peleg, T Frumkin, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2010
Detection of early-stage pancreatic adenocarcinomaDavid V Gold, Michael Goggins, David E Modrak, et al.
Cell Death and Differentiation|April 3, 2004
BMP controls nitric oxide-mediated regulation of cell numbers in the developing neural tubeA Traister, S Abashidze, V Gold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphyThomas M Cardillo, Habibe Karacay, David M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2009
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabineHabibe Karacay, Robert M Sharkey, David V Gold, et al.
Cancer Research|February 1, 1990
Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigensR M Sharkey, D V Gold, R Aninipot, et al.
Cancer Research|June 19, 2008
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinomaDavid V Gold, David M Goldenberg, Habibe Karacay, et al.
Cancer Research|December 1, 1995
Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancerG Mariani, N Molea, D Bacciardi, et al.
International Journal of Cancer|July 29, 2011
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivoDavid M Goldenberg, David Zagzag, Kerstin M Heselmeyer-Haddad, et al.
Molecular Cytogenetics|March 22, 2022
New insights regarding origin of monosomy occurrence in early developing embryos as demonstrated in preimplantation genetic testingN Samara, S Peleg, T Frumkin, et al.
Cancer Research|April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumorsT M Behr, R M Sharkey, M I Juweid, et al.
Pageof 8